QM · rank #20 · 2026-07-24
MKSI
NASDAQ · $23.32B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +291.92% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +12.7% |
| Profit margin Net profit margin, trailing 12 months. | +8.0% |
| Market cap (USD) Size filter: > $500M required. | $23.32B |
| Anchor (recent) Close on 2026-06-24 | $381.62 |
| Anchor (far) Close on 2025-06-24 | $97.37 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
MKS Instruments is a global supplier of enabling technologies, instruments, and chemistry solutions critical to semiconductor and advanced electronics manufacturing, with roughly 40% of revenue from recurring services and consumables.
Rationale
The momentum_12_1 signal of 2.92 is reinforced by a concrete fundamental catalyst — 15% YoY revenue growth, a double-digit Q1 EPS beat, and accelerating Q2 guidance — while ROE of 12.7% and 8% profit margins confirm the quality screen is capturing real earnings power, not just sentiment rotation.
Material risks
- 1Cyclical semiconductor capex reversal is the primary thesis-breaker — if AI infrastructure spending decelerates, MKSI's order flow and utilization rates compress rapidly given its exposure to equipment and process chemistry tied to fab build-out cycles.
- 2The $2.5B+ secured term loan stack maturing in 2029 creates meaningful refinancing and leverage risk; any deterioration in earnings or credit conditions could pressure the balance sheet and divert capital from growth investment at precisely the wrong moment in the cycle.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.